Filters
Documents
Showing 25 of 828 items meeting your criteria.
| Type | Category | Supplier | ||
|---|---|---|---|---|
 | Abnova provides a range of FISH probes for clinical applications. | |||
Documents | Probes | Abnova Corporation | ||
 | Abnova provides a range of exosome biomarker antibodies. | |||
Documents | Antibodies | Abnova Corporation | ||
 | Abnova provide a range of antibodies specifically for endometrial cancer. | |||
Documents | Cancer | Abnova Corporation | ||
 | miRNA probes are short RNA molecules used to identify and localize microRNAs (miRNAs) present in biological samples. They are designed to be complementary to the target miRNA sequence, allowing them to form a stable duplex with the miRNA and facilitating the detection and quantification of miRNAs. With Abnovas state-of-the-art custom miRNA probe service, they offer you the power to design and tailor high-quality miRNA probes specific to your research needs. | |||
Documents | Service | Abnova Corporation | ||
 | Circulating tumour cell (CTC)-derived xenografts (CDx) offer an opportunity for those patients that cannot undergo an invasive procedure to generate tumoUr models and assess their potential roles in tumour progression and management. | |||
Documents | Cancer | Abnova Corporation | ||
 | Abnova provides a range of antibodies specifically for colorectal cancer. | |||
Documents | Cancer | Abnova Corporation | ||
 | Abnova provide a range of Cancer Epigenetics polyclonal and monoclonal antibodies | |||
Documents | Cancer | Abnova Corporation | ||
 | Abnova provide a range of recombinant monoclonal antibody cancer biomarkers. | |||
Documents | Cancer | Abnova Corporation | ||
 | Product list of Bioreagents for FDA-Approved Therapeutic Mabs and Anti-Drug Mabs | |||
Documents | ELISA | Abnova Corporation | ||
 | Abnova Bioactive Proteins Product Lists | |||
Documents | Proteins | Abnova Corporation | ||
 | A selection of Abnovas Best-in-Class Bioreagents | |||
Documents | Catalogue | Abnova Corporation | ||
 | Abnova provides a range of Autophagy antibodies. | |||
Documents | Autophagy | Abnova Corporation | ||
 | HER2, EGFR, HER3, and IGF-1R dimerized with the HER2 receptor induce activation of PI3K/AKT and MAPK/MEK signalling pathways and receive signals to regulate the downstream cascade that promotes the active transcription of genes involved in proliferation, angiogenesis, cell survival, and metastasis. | |||
Documents | Transcription Factors | Abnova Corporation | ||
 | Abnova provides a range of Apoptosis biomarkers. | |||
Documents | Apoptosis | Abnova Corporation | ||
 | Abnova Corporation provides Antibodies & Proteins Specific for Coronaviruses | |||
Documents | COVID-19 | Abnova Corporation | ||
 | Abnova Corporation provides a range of Acute Myeloid Leukemia Antibodies. | |||
Documents | Cancer | Abnova Corporation | ||
 | Abnova offers Antibody Drug ELISA Kits. | |||
Documents | ELISA | Abnova Corporation | ||
 | Abnova provides Cell Therapy GMP Grade Proteins | |||
Documents | Recombinant Proteins | Abnova Corporation | ||
 | Diaclone proposes a complete range of Antibodies, Immunoassays and Recombinant proteins for your SARS-CoV-2 research projects. | |||
Documents | COVID-19 | Diaclone | ||
 | The ELISpot Assay is a versatile and highly sensitive method for ex-vivo analysis of protein secretion post cell stimulation. Virtue of its high sensitivity (1 cell in 100,000) the ELISpot assay enables frequency analysis of activated cell populations or antigen-specific cell responses at the single cell level and therefore can measure the magnitude of specific T-cell immunity. | |||
Documents | ELISpot | Diaclone | ||
 | Silensomes™ are validated human pooled liver microsomes (HLMs) chemically and irreversibly inactivated for one specific CYP450 using mechanism based inhibitors (MBI). | |||
Documents | Cell Biology | Biopredic | ||
 | Biopredics HSCs have cell quality post-thawing, specific marker expression post-thawing/plating and are quiescent 6 days after culture in a reversion medium. | |||
Documents | Primary Cells | Biopredic | ||
 | Nordic-MUbio is pleased to announce the release of one of the original antibodies (MUB2058) developed for the identification and characterisation of Thy-1 (CD90) in rats, used in some of the highly cited work of Barclay et al. | |||
Documents | Antibodies | Nordic MuBio | ||
 | FIX&PERM® is a simple procedure making use of two reagents. Reagent A gently fixes cells, while Reagent B permeabilises them. | |||
Documents | Kits | Nordic MuBio | ||
 | Why choose Elabscience ELISA Kits? Strict quality control, authoritative recognition and efficient service. | |||
Documents | ELISA | Elabscience | ||